Latest News

Bruce Dorr, MD, FACOG, URPS, FMCP-M, and Maria Uloko, MD, walk through real-world dosing, cost workarounds, and the labs that actually matter for safety and efficacy.

Bruce Dorr, MD, FACOG, URPS, FMCP-M, and Maria Uloko, MD, reframe testosterone candidacy around clinical presentation and hormone state, not age cutoffs or a single number on a chart.

Before prescribing testosterone, know what the evidence actually proves. Maria Uloko, MD, draws a sharp line between the one population the data supports and the much wider group of women asking about it.

Drawing on her own successful version, Amber Watters, MD, welcomes the ASA's push for closer obstetrics and anesthesia collaboration.

David Shalowitz, MD, MSHP, emphasizes spreading awareness of opportunistic salpingectomy across specialties while grounding its use in shared decision-making.

SMFM states abortion care is core to MFM practice and urges institutional action to protect high-risk patient access.

Hugh Taylor, MD, welcomes ACOG's new guidance allowing clinical, nonsurgical diagnosis of endometriosis and emphasizes it is a systemic disease affecting the whole body.

FDA accepted for review an sNDA for MIUDELLA copper IUD for a 6-year duration, with a PDUFA date in Q2 2027.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

Positively Pregnant translates cycle day and cycle length research into individualized pregnancy test sensitivity estimates, according to Alexandra C. Sundermann, MD, PhD.

Kevin Ault, MD, FACOG, explains that all four vaccines in ACOG's 2026-27 guidance carry direct newborn benefit and that prenatal conversations ease downstream pediatric vaccine discussions.

A new SFP Committee Statement in Contraception standardizes protocols for removing deep and nonpalpable contraceptive implants.

Atogepant reduced perimenstrual migraine days vs. placebo and met all 8 secondary endpoints in the Phase 3 LUNA study.

A new, expert-led video series explores the PCOS-to-PMOS rename and what it means for diagnosis, care, and outcomes.

Kevin Ault, MD, FACOG, emphasizes that obstetric clinicians are patients' most trusted vaccine information source, making maternal COVID-19 counseling a high-value opportunity.

FDA granted BTD to certolizumab pegol for preventing adverse pregnancy outcomes in women with antiphospholipid syndrome.

Amber Watters, MD, MS, explains how the ASA's statement encourages obstetric units to integrate neuraxial anesthesia into a formal external cephalic version process.

David Shalowitz, MD, MSHP, describes how OB-GYNs can collaborate with non-gynecologic surgeons to extend salpingectomy and reduce ovarian cancer risk during other abdominal procedures.

Positively Pregnant, built on PRESTO data, gives patients day-specific, evidence-based estimates of home pregnancy test accuracy by cycle timing, as Alexandra C. Sundermann, MD, PhD, explains in this video.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

Kevin Ault, MD, FACOG, explains that maternal COVID-19 and influenza vaccination protects newborns and reduces severe maternal illness, stillbirth, and prematurity.

"Although availability of certain products or brands may vary by pharmacy or location, estradiol transdermal patches remain available," stated the federal agency in an update.

Kevin Ault, MD, FACOG, explains ACOG's extension of the maternal RSV vaccine window to March 1 and the role of passive immunity in protecting newborns.

David Shalowitz, MD, MSHP, explains that stronger effectiveness and safety data in average-risk patients drove ACOG's strengthened salpingectomy recommendation.

A meta-analysis of 47,000+ GLP-1-exposed pregnancies found no increased risk of major complications, although Elizabeth Jasper, PhD, cautions evidence remains limited.

ACOG strongly recommends COVID-19, RSV, and flu vaccines for pregnant patients ahead of the 2026–27 respiratory season.

A recap of the top stories from August 2026 in women's health.

Take a look back at some of the top FDA and pipeline news in women's health from August 2026.

Experts weigh GLP-1 therapy's promise for PMOS against the risks of overly rapid weight loss in teens.

Experts break down which labs actually change PMOS management and how to avoid diagnostic pitfalls.

Experts outline when primary care should manage PMOS versus refer, and why insulin resistance matters.